PRPH
ProPhase Labs, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$0.02
+17.65%Leverage
- Debt / equity
- -2.93x
- Net debt / equity
- -2.93x
- Debt / assets
- 0.16x
- Debt / EBITDA
- -1.28x
- Net debt / EBITDA
- -1.27x
Liquidity & coverage
- Current ratio
- 0.05x
- Quick ratio
- 0.05x
- Cash ratio
- 0.00x
- Interest coverage
- -2.17x
- EBITDA / interest
- -0.99x
- Working capital
- -$55.3M
Cash & dividend
- FCF / debt
- -3.36x
- Cash flow / debt
- -3.36x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- +100.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026